Arca Biopharma sell StockNews.com
Start price
20.04.24
/
50%
€3.16
Target price
20.04.25
-
Performance (%)
12.03%
Price
02.07.24
€3.54
Summary
This prediction is currently active. The prediction currently has a disappointing performance of 12.03%. This prediction currently runs until 20.04.25. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Arca Biopharma | 0.000% | 0.000% |
iShares Core DAX® | 1.395% | -0.696% |
iShares Nasdaq 100 | 2.287% | 7.501% |
iShares Nikkei 225® | 1.617% | 2.769% |
iShares S&P 500 | 0.659% | 4.280% |
Comments by StockNews_com for this prediction
In the thread Arca Biopharma diskutieren
ARCA biopharma, Inc. (NASDAQ: ABIO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ABIO provided by MarketBeat